Rhythm Pharmaceuticals (STU:1RV) Inventories, Finished Goods : €2.52 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rhythm Pharmaceuticals Inventories, Finished Goods?

Rhythm Pharmaceuticals's quarterly finished goods increased from Sep. 2023 (€1.11 Mil) to Dec. 2023 (€2.66 Mil) but then declined from Dec. 2023 (€2.66 Mil) to Mar. 2024 (€2.52 Mil).

Rhythm Pharmaceuticals's annual finished goods increased from Dec. 2021 (€0.10 Mil) to Dec. 2022 (€0.18 Mil) and increased from Dec. 2022 (€0.18 Mil) to Dec. 2023 (€2.66 Mil).

Rhythm Pharmaceuticals Inventories, Finished Goods Historical Data

The historical data trend for Rhythm Pharmaceuticals's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Inventories, Finished Goods Chart

Rhythm Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.10

0.18

2.66

Rhythm Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															0.74	0.88	1.11	2.66	2.52

Rhythm Pharmaceuticals Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Rhythm Pharmaceuticals (STU:1RV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (STU:1RV) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

RYTM:USA RYTM:Mexico

Address

222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116

Website

http://www.rhythmtx.com

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Rhythm Pharmaceuticals (STU:1RV) Headlines

No Headlines